An Evaluation of
Electrocochleography as a
Diagnostic Tool for Ménière’s Disease
______
A thesis submitted in partial fulfilment of the
requirements for the Degree of
Master of Audiology
in the Department of Communication Disorders
at the University of Canterbury
By
Catherine J. Kalin
______
University of Canterbury
2010 ii
Acknowledgments ______
This master’s thesis could not have been completed without the help and support of many people. I would like to express my gratitude to my two primary supervisors, Dr. Emily Lin and Professor Jeremy Hornibrook, who not only served as my supervisors but also encouraged and challenged me throughout my masters study program. Their passion for research was an inspiration to me, and I would like to thank them both sincerely for the guidance and support they have given me over the past year. I would also like to thank my co supervisor, Dr Greg O’Beirne, for his help and support with my academic writing.
I gratefully acknowledge John Gourley and the audiology staff at Christchurch
Hospital who have been involved with electrocochleography recordings over the last
15 years. I would like to thank Angela Harrison at Christchurch Hospital and Glynis
Whittaker at the private practice of Mr Hornibrook for the retrieval of the data files. I also wish to thank all the research participants for their contributions in this study. I sincerely thank you all for allowing me to have access to your medical files.
Finally, I would like to acknowledge the loving support of my friends and family. To my fellow postgraduate students, I am most grateful for your ongoing support, encouragement and company. I especially want to thank Mark, for his moral support, unfailing patience and encouragement. Finally, I would like to make a very special thank you to my parents, Murray and Glenys. Thank you for your support and always believing in me. iii
Abstract ______
Ménière’s disease (MD) is an idiopathic inner ear disorder, characterised by episodes of vertigo, tinnitus, sensorineural hearing loss, and aural fullness in the affected ear. The relatively high variability of symptomological changes renders it difficult to confirm the MD diagnosis. The purpose of this study is to compare the diagnostic power of an instrumental method, electrocochleography (ECochG), and two subjective methods, including the criteria based on the clinical guidelines provided by the American Academy of Otolaryngology Head and Neck Surgery
Committee on Hearing Equilibrium (AAO HNS CHE) and Gibson’s Score.
A quota sampling method was used to include subjects. A total of 250 potential MD patients who were referred to the Department of Otolaryngology at the
Christchurch Hospital between year 1994 and 2009 have had their signs and symptoms documented and ECochG testing completed. A selection of details obtained from both AAO HNS CHE and ECochG assessment results were examined as a chart review in regard to its function as a diagnostic tool for MD.
The between method reliability was found to be high, with a few disagreements on individual diagnosis. Based on a receiver operating characteristic
(ROC) curve analysis, the ECochG measures were shown to be pertinent to the diagnosis of MD. It was also found that patients tested “positive”, as compared with those tested “negative”, tended to show higher correlations among the four key symptoms of MD and among the ECochG measures derived from the auditory evoked responses to tone bursts at frequencies in close proximity to each other. iv
Table of Contents ______
Acknowledgments ...... ii Abstract...... iii Table of Contents ...... iv List of Figures...... vi List of Tables ...... x
Chapter One: Introduction ...... 1 1.1 Overview...... 1 1.2 Literature Review...... 2 1.2.1 Ménière’s Disease (MD)...... 3 1.2.1.1 Aetiology and Prevalence...... 3 1.2.1.2 Audiometric Configuration...... 4 1.2.2 Subjective Assessment of MD ...... 6 1.2.2.1 AAO HNS CHE Criteria...... 6 1.2.2.1.1 The AAO HNS CHE Guidelines...... 6 1.2.2.1.2 Assessment of the AAO HNS CHE Guidelines ...... 11 1.2.2.2 Gibson’s Score...... 12 1.2.3 Electrocochleography...... 14 1.2.3.1 Electrocochleographic Auditory Evoked Responses...... 15 1.2.3.2 ECochG Recording Techniques ...... 18 1.2.3.3 Acoustic Stimulus...... 19 1.2.3.4 Endolymphatic Hydrops...... 21 1.2.4 Magnetic Resonance Imaging...... 23 1.2.5 Treatment of MD and the Impact of Diagnosis ...... 24 1.3 Research Question ...... 26 1.3.1 Rationale and Importance ...... 26 1.3.2 Aims and Hypotheses...... 26 Chapter Two: Methodology...... 28 2.1 Participants and Participants’ Task...... 28 2.2 Instrumentation ...... 29 2.3 Procedure ...... 31 v
2.4 Measurements ...... 32 2.4.1 Pure Tone Audiometry Measurements...... 32 2.4.2 AAO HNS CHE Measurements ...... 32 2.4.3 Gibson’s Score Measurements...... 32 2.4.4 Electrocochleography Measurements ...... 33 2.5 Data Analysis...... 33 2.6 Statistical Analysis...... 35 2.7 Ethical Considerations ...... 37 Chapter Three: Results ...... 38 3.1 Agreement between Diagnostic Tools ...... 38 3.1.1 ROC Curves for AAO HNS CHE Criteria and Gibson’s Score...... 38 3.1.2 Inter method Reliability...... 41 3.1.2.1 ECochG and AAO HNS CHE Criteria...... 42 3.1.2.2 ECochG and Gibson’s Score...... 44 3.1.2.3 Gibson’s Score and AAO HNS CHE Criteria...... 46 3.1.2.4 Tone burst and Click ECochG...... 47 3.2 Comparisons between “Positive” and “Negative” ECochG Cases...... 48 3.2.1 Relationships between Symptoms of MD...... 49 3.2.2 Hearing Loss Patterns ...... 52 3.2.3 Relationships between ECochG Measures...... 57 3.2.4 Demographic Information...... 60 3.3 Summary of Main Findings ...... 66 Chapter Four: Discussion...... 68 4.1 The Agreement between Diagnostic Tools...... 68 4.2 Evaluation of Electrocochleography...... 71 4.3 Findings of the Study in Relation to Previous Research...... 74 4.4 Clinical Implications...... 76 4.5 Limitations of the Study and Future Direction ...... 76 4.6 Conclusion ...... 77 References...... 79 Appendix 1...... 85 Appendix 2...... 89 Appendix 3...... 92
vi
List of Figures ______
Figure 1. The waveforms (X axis: time; Y axis: amplitude) of the
combined signals of the cochlear microphonic (CM) and
summating potential (SP) in the top graph, the SP waveforms in
the middle graph, and the waveform of the acoustic stimulus in
the bottom graph (adapted from Ferraro & Durrant, 2002, p. 251)...... 16
Figure 2. A normal ECochG trace using alternating clicks at 80 dB HL.
The amplitudes of the SP and AP can be measured by either a
peak to trough (left graph) or a baseline reference (right graph)
demarcation method where the SP is subtracted from the AP
(Ferraro, 2000, p. 435) ...... 17
Figure 3. Upper trace illustrates an ECochG recording in response to a 2
kHz tone burst stimulus in an ear with no endolymphatic hydrops
(copied from Ferraro, 2000; p. 436). The middle trace illustrates
response to a click stimulus and the lower trace response to a tone
burst stimulus in an ear with endolymphatic hydrops (copied from
Gibson, 2009; p.39)...... 20
Figure 4. The SP waveforms in response to a 90 dB HL stimulus at
different frequencies as measured in a normal ear (left graph) and
in a Ménière’s ear (right graph) (copied from Gibson, 1996; p.14) .....22
Figure 5. Instrumentation setup...... 30
Figure 6. Receiver operating characteristic (ROC) curve showing the
relationship between sensitivity and 1 specificity of the Gibson’s vii
score test at 11 cut off points (right to left from 0 to10) and that
of the AAO HNS CHE test at 3 cut off points (“possible”,
“probable”, and “definite”) ...... 39
Figure 7. Percentage of patients identified as “positive” and “negative”
respectively using different diagnostic methods, including
ECochG, AAO HNS CHE criteria with only “Definite” as
“positive” (AAO Definite), AAO HNS CHE criteria with both
“Definite” and “Probable” as “positive” (AAO
Definite/Probable), and Gibson’s score with the cutt off point at a
value of 7...... 41
Figure 8. Total, point by point, occurrence and non occurrence reliability
between ECochG measures and AAO HNS CHE criteria,
between ECochG measures and Gibson’s score, and between
AAO HNS CHE criteria and Gibson’s score...... 42
Figure 9. The respective distribution of “positive” and “negative” ECochG
cases across the three categories of AAO HNS CHE criteria ...... 44
Figure 10. The respective distribution of “positive” and “negative” ECochG
cases across different levels of Gibson’s score...... 45
Figure 11. The respective distribution of “positive” and “negative” AAO
HNS CHE cases across different levels of Gibson’s score...... 46
Figure 12. Number of “positive” tone burst and Click ECochG results ...... 47
Figure 13. Percentage of patients showing each of the four key symptoms of
MD ...... 50
Figure 14. The respective distribution of “positive” and “negative” ECochG
cases across different levels of hearing loss ...... 53 viii
Figure 15. The respective distribution of “positive” and “negative” ECochG
cases across three types of between ear contrast on hearing loss.
Significantly different between type comparisons were marked
with different letters. Significantly different between diagnosis
comparisons were marked with an asterisk (“*”) ...... 54
Figure 16. The respective distribution of “positive” and “negative” ECochG
cases across two different levels of between ear threshold
differences...... 55
Figure 17. Means and standard deviations of hearing threshold as measured
at 0.5, 1, 2 and 4 kHz frequencies for the “positive” and
“negative” ECochG groups...... 56
Figure 18. Means and standard deviations of the coefficient of variation (for
tone burst ECochG across frequencies) obtained from the
“positive” and “negative” patients as classified by three
diagnostic methods, including ECochG, AAO HNS CHE criteria
with only “Definite” as “positive”, and Gibson’s score with the
cut off point at a value of 7...... 60
Figure 19. Percentage of “positive” ECochG cases in each gender...... 61
Figure 20. Ethnicity of all the 250 patients included in this study...... 62
Figure 21. Percentage of “positive” ECochG cases in each age range as
compared to the AAO HNS CHE diagnosis...... 63
Figure 22. Percentage of “positive” ECochG cases presenting with a
unilateral left or right ear or a bilateral sign of MD...... 64
Figure 23. The number of patients identified as having bilateral Ménière’s
Disease ...... 65 ix
Figure 24. The total number of ears tested as shown in the Gibson score
from the AAO HNS CHE diagnosis...... 66 x
List of Tables ______
Table 1. 1972 AAO HNS CHE Criteria for the diagnosis of Ménière’s
disease (adapted from Committee on Hearing and Equilibrium,
1972; p. 1464) ...... 7
Table 2. 1985 AAO HNS CHE Criteria for the diagnosis of Ménière’s
disease (adapted from Committee on Hearing and Equilibrium,
1985; p. 6 7)...... 8
Table 3. 1995 AAO HNS CHE Criteria for the diagnosis of Ménière’s
disease (adapted from Members of the Committee on Hearing and
Equilibrium, 1995; p. 182)...... 10
Table 4. The point system of Gibson’s Score (adapted from Gibson, 1991;
p. 109) ...... 13
Table 5. Electrocochleography norms (adapted from Gibson, 1994)...... 34
Table 6. Formula for calculating the diagnostic power of the two
subjective tests respectively as compared with ECochG diagnosis...... 36
Table 7. Conditions given for the calculation of four types of inter method
reliability...... 37
Table 8. Correlations (Pearson’s r) between SP/AP ratios at from Click
ECochG and that from Tone burst ECochG at 500, 1,000, 2,000
and 4,000 Hz in the “positive” (POS) and “negative” (NEG) cases
classified by three diagnostic methods ...... 48 xi
Table 9. Correlations (Spearman rho) between the four key symptoms in
the “positive” (POS) and “negative” (NEG) cases classified by
three diagnostic methods...... 51
Table 10 Correlations (Pearson’s r) between SP/AP ratios at 0.5, 1, 2 and 4
kHz in the “positive” (POS) and “negative” (NEG) cases
classified by three diagnostic methods ...... 58
1
Chapter One: Introduction ______
This study concerns the agreement on the diagnosis of Ménière’s disease
(MD) between an instrumental measure, electrocochleography (ECochG), and two subjective measures, including the clinical guidelines specified by the American
Academy of Otolaryngology Head and Neck Surgery Committee on Hearing
Equilibrium (AAO HNS CHE) and the Gibson scale. This chapter provides an overview of the rationale behind the investigation, a literature review, the research question, its importance and related aims and hypotheses.
1.1 Overview
Ménière’s disease is an idiopathic inner ear disorder (Menière, 1861; Ries,
Rickert, & Schlauch, 1999). It is characterised by episodes of vertigo, roaring tinnitus, fluctuating sensorineural hearing loss, and a sense of aural fullness in the affected ear, with a combination of these signs and symptoms fluctuating over months and years (Sajjadi & Paparella, 2008). Vertigo can be experienced in two ways, with the sensation of oneself spinning through space being referred to as “subjective vertigo” and that of the environment spinning around oneself as “objective vertigo”
(Bhatnagar, 2002). Episodes of vertigo which can last for several minutes or hours are often associated with nausea and vomiting (Hall, 2007). Fluctuating tinnitus and sensations of fullness in the ear can worsen during vertigo attacks (Valente,
Hosoford Dunn, & Roeser, 2008). These symptoms may fluctuate in frequency and severity for different individuals, resulting in difficulties in the diagnosis of MD. 2
The aetiology of MD has been linked to endolymphatic hydrops, with evidence from histological studies (Hallpike & Cairns, 1938; Horner, 1991).
Endolymphatic hydrops refers to swelling of cochlea at the boundaries of the scala media from excessive accumulation of the endolymph (Hall, 2007). Treatment of MD can be difficult and controversial because the exact aetiology of MD is unknown and a complete remedy has not been developed. Several treatment options are available depending on an individual’s symptoms and responses to previous treatments.
Lifestyle changes, such as a low salt diet and avoidance of tobacco products, caffeine, alcohol, and chocolate, may be made to alleviate the symptoms before the administration of drugs and surgical intervention (Sajjadi & Paparella, 2008).
Although MD has been extensively studied clinically and experimentally, little is known about the precise pathophysiology. The diagnosis of MD is normally made using the clinical guidelines set by the AAO HNS CHE based on a selection of signs and symptoms (Members of the Committee on Hearing and Equilibrium, 1995).
Other measurements, such as Gibson’s Score, electrocochleography, and more recently, magnetic resonance imaging (MRI), have also been used to assist in the diagnosis of MD (Gibson, 1990; Nakashima et al., 2009). However, the histological information and thus the confirmation of a MD diagnosis can only be obtained through post mortem biopsies (Roeser, Valente, & Hosford Dunn, 2000). Therefore, the administration of appropriate clinical diagnostic tools and treatment remains a challenging task.
1.2 Literature Review
This literature review provides the theoretical framework and previous findings regarding a variety of approaches in the diagnosis of MD. Specifically, this 3 review covers topics related to MD, AAO HNS CHE criteria, Gibson’s Score,
ECochG, and MRI of the inner ear.
1.2.1 Ménière’s Disease (MD)
In 1861, Prosper Ménière described the typical characteristics of MD
(Menière, 1861; Morrison, 1997; Thorp & James, 2005; Sajjadi & Paparella, 2008;
Vrabec, Simon, & Coker, 2007) based on the work of Pierre Flourens, along with his own observations of patients with vertigo, hearing loss, and tinnitus. Pierre Flourens surgically removed the semicircular canals in a pigeon and found the removal resulted in a loss of balance that was oriented in the same direction as the removed semicircular canal (Baloh, 2001; Flourens, 1824; Thorp & James, 2005). Although not well received at the time, Prosper Ménière concluded that the main clinical signs and symptoms of MD were tinnitus, progressive hearing loss, and vertigo attacks, and the cause was likely to be a lesion located in the semicircular canals (Thorp & James,
2005; Sajjadi & Paparella, 2008).
1.2.1.1 Aetiology and Prevalence
The aetiology of MD has been studied extensively. According to Horner
(1993), endolymphatic hydrops was first discovered in the temporal bones of MD patients by Hallpike and Cairns (1938), who coined the term “endolymphatic hydrops” in referring to a swelling (edema) of the scala media within the cochlea
(Hall, 2007). It has been hypothesized that the cause of the swelling was either endolymphatic pressure or the K + intoxication of the perilymph from the endolymph
(Horner, 1991). Horner (1991) surgically induced endolymphatic hydrops in guinea pigs to investigate the effects and found both hypotheses equally plausible.
According to Horner (1993), many studies with similar experimental trials have been 4 conducted on different animals but none have proven a definitive cause of the edema of the scala media within the cochlea.
Several estimates of the prevalence of MD have been published. These results vary broadly depending on the population studied. An estimated 513 per 100,000 was reported for a Finnish population (Havia, Kentala & Pyykkö, 2005) and 17 per
100,000 for a homogeneous Asian population (Watanabe et al., 1995). The large variations on the estimated prevalence across countries may be due to the between study differences in the information available at the time of the research, the way subjects were assessed and selected, cultural and therefore lifestyle differences and the average age of the populations of concern (Havia, Kentala & Pyykkö, 2005).
Although the prevalence of MD is generally considered unknown (Costa, Sousa &
Piza, 2002), Paparella, da Costa, Fox & Yoo (1991) noted that MD was more common in adults in their fourth or fifth decade of life. Vrabec, Simon, & Coker
(2007), in studying the prevalence of definite MD cases based on a review of the medical records of patients seen between 2001 2003 in a hospital in the USA
(Houston, Texas), also concluded from the identified 190 MD cases that the mean age of onset for MD was 45.9 years of age.
In summary, researchers have been generally consistent in the findings of the mean age of onset of MD, as well as the association between MD and endolymphatic hydrops and various risk factors, while the prevalence and the underlying pathophysiology of MD remain largely unclear.
1.2.1.2 Audiometric Configuration
Hearing loss in those with MD often occurs unilaterally but can also occur bilaterally (Thorp & James, 2005). Sensorineural hearing loss (SNHL) was found to fluctuate in the early stages of MD, with the loss typically starting from low 5 frequencies. After 8 10 years from onset, the hearing loss usually stabilizes at a moderate to severe sensorineural hearing loss (Vrabec, Simon, & Coker, 2007).
Audiometric configuration has been studied in relation to endolymphatic hydrops, a major feature of MD (Horner, 1991). For example, Horner (1993) found in guinea pigs that induced endolymphatic hydrops resulted in a peaked audiometric configuration. The loss of hearing sensitivity was found to start at low frequencies, progress to high frequencies, showing a mid frequency ‘peak’ in the audiogram, and finally include mid frequencies at a later stage. In a retrospective study, Ries, Rickert and Schlauch (1999) compared the audiometric configurations of individuals with unilateral MD, those with unilateral acoustic tumor, and those from a general clinical population of an audiology clinic. It was found that 17% (13.6/80) of the participants with unilateral MD showed a peaked audiometric configuration in one ear and flat audiometric configuration in the other. In comparison, 12.5% (7/56) of participants with unilateral acoustic tumor and 9% (8/89) of participants in the general clinical population also presented with a peaked audiometric configuration. This finding indicated that individuals with MD had a higher incidence of peaked audiometric configuration but it could not be concluded that the peaked audiometric configuration was pathognomonic of MD. Furthermore, McNeill, Cohen and Gibson (2009) examined the hearing change of six individuals with MD before, during and after attacks of vertigo. The study showed that five of the subjects showed less than a 10 dBHL change in their audiometric hearing threshold at all frequencies tested before, during and after an attack of vertigo. One patient showed some deterioration of hearing before the vertigo attack only. It was, therefore, suggested that hearing thresholds did not alter significantly before, during or after vertigo attacks for individuals with MD. 6
1.2.2 Subjective Assessment of MD
Several methods can be used to assist in the assessment of individuals with
MD. In common practice, a subjective assessment following AAO HNS CHE criteria or the Gibson scale is used for the diagnosis of MD. For diagnostic purpose, these subjective assessment methods can be used on their own or in combination with an instrumental approach, such as ECochG measures.
1.2.2.1 AAO H S CHE Criteria
The AAO NHS CHE approach to the diagnosis of MD is summarised in a set of guidelines that were published to standardise the diagnostic criteria. These guidelines were first published in 1972, and then revised in 1985 and 1995
(Committee on Hearing and Equilibrium, 1972; Committee on Hearing and
Equilibrium, 1985; Members of the Committee on Hearing and Equilibrium, 1995).
1.2.2.1.1 The AAO H S CHE Guidelines
In 1972, the first standard for MD diagnosis was established by the American
Academy of Otolaryngology Head and Neck Surgery Committee on Hearing and
Equilibrium using a letter designation system to categorize various forms of patient presentations. The categorization of this method is based on the consistency of the presence of vertigo spells in relation to hearing status (Committee on Hearing and
Equilibrium, 1972). The four categories with their associated descriptions are shown in Table 1. In 1985, the AAO NHS CHE guidelines for the diagnosis of MD were revised as there were several suggestions made to improve the reporting of the symptoms. Instead of employing only qualitative descriptors as in the previous criteria, this revision incorporated the use of a formula to reflect the change of vertigo spells with the frequency of the vertigo attack taken into consideration (Committee on 7
Hearing and Equilibrium, 1985). The formula expresses the effect that treatment has on the vertigo spells. A ratio of the average number of vertigo attacks per month for a
24 month period following initial treatment to that for a 6 month period before treatment is calculated. Hearing is assessed using a four frequency pure tone average
(PTA) at 500 Hz, 1 kHz, 2 kHz, and 3 kHz. A change in hearing is determined by comparing pre and post treatment PTA values. Finally, the degree of disability caused by the disease in the affected individual was noted both before and after treatment. The formula and the criteria set for different degrees of disability are shown in Table 2.
Table 1. The 1972 AAO HNS Criteria for the diagnosis of Ménière’s disease (adapted from
Committee on Hearing and Equilibrium, 1972; p. 1464).
Class Criteria
A Absence of definitive spells for described period (in addition, absence
of adjunctive spells as well could be so noted)